Patent details

EP3202459 Title: ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF FOR TREATING OBESITY OR TYPE 2 DIABETES BY REGULATING BODY FAT CONTENT

Basic Information

Publication number:
EP3202459
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161953799
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English Title of Invention:
ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF FOR TREATING OBESITY OR TYPE 2 DIABETES BY REGULATING BODY FAT CONTENT
French Title of Invention:
ANTAGONISTES D'ACTRIIB ET DOSAGE ET UTILISATIONS DE CEUX-CI POUR TRAITER L'OBÉSITÉ OU LE DIABÈTE EN RÉGULANT LE TAUX DE GRAISSE CORPORELLE
German Title of Invention:
ACTRIIB-ANTAGONISTEN SOWIE DOSIERUNG UND VERWENDUNGEN DAVON ZUR BEHANDLUNG VON FETTLEIBIGKEIT ODER TYPE 2 DIABETES DURCH KÖRPERFETTKONTROLLE
SPC Number:

Dates

Filing date:
09/09/2010
Grant date:
14/04/2021
EP Publication Date:
09/08/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/04/2021
EP B1 Publication Date:
14/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/09/2021
Expiration date:
09/09/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/04/2021
 
 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:
SEEHRA, Jasbir
Address:
United States (US)

2

Name:
KNOPF, John
Address:
United States (US)

3

Name:
ATTIE, Ken
Address:
United States (US)

Priority

Priority Number:
276287 P
Priority Date:
09/09/2009
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/705; A61K 38/17; A61K 31/663; A61P 3/04;

Publication

European Patent Bulletin

1

Issue number:
202115
Publication date:
14/04/2021
Description:
Grant (B1)

2

Issue number:
202120
Publication date:
19/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages